SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

Syros Pharmaceuticals Q1 EPS $(0.390) Beats $(0.430) Estimate, Sales $2.379M Beat $1.620M Estimate

Syros Pharmaceuticals (NASDAQ:SYRS) reported quarterly losses of $(0.390) per share which beat the analyst consensus estimate of $(0.430) by 9.3 percent. This is a 20.41 percent increase over losses of $(0.490) per share

Benzinga · 05/07/2020 11:49

Syros Pharmaceuticals (NASDAQ:SYRS) reported quarterly losses of $(0.390) per share which beat the analyst consensus estimate of $(0.430) by 9.3 percent. This is a 20.41 percent increase over losses of $(0.490) per share from the same period last year. The company reported quarterly sales of $2.379 million which beat the analyst consensus estimate of $1.620 million by 46.85 percent. This is a 424.01 percent increase over sales of $454.000 thousand the same period last year.